The interim DIPG combo data is imminent if the schedule of milestones is somewhat correct and there are a few conferences in the coming 4 months, most notably SNO in June where the DIPG data is well placed.
https://www.soc-neuro-onc.org/WEB/WEB/Events.aspx
If the data is relatively in line with the experience from case reports then I translate previous JG's comments on the willingness of regulatory bodies to look at the evidence in such underserved, high-need areas as "We will align our regulatory strategy with Chimerix and prepare the documents for a (conditional) regulatory approval".
- Forums
- ASX - By Stock
- DIPG Panel Discussion
The interim DIPG combo data is imminent if the schedule of...
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)